Synthetic biology is trucking along, but "more solid science" is needed, Craig Venter tells Bloomberg Businessweek. "I have been sure we're about to solve all the problems, and next year people will say, 'Where is it?' We have not done it yet,'" he adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.